See the DrugPatentWatch profile for mounjaro
Does Mounjaro Cause Low Blood Pressure?
Mounjaro (tirzepatide) lists low blood pressure (hypotension) as a possible side effect, primarily in patients with dehydration or low blood volume from gastrointestinal issues like nausea, vomiting, or diarrhea. Clinical trials reported hypotension in less than 1% of participants, often linked to these factors rather than the drug directly.[1][2]
How Common Is Hypotension with Mounjaro?
In the SURPASS trials, which supported FDA approval, hypotension occurred in 0.4-1.1% of Mounjaro users versus 0.4% on placebo. It's more frequent at higher doses (10-15 mg) and in those with pre-existing conditions like kidney issues or on blood pressure medications.[2][3] Post-marketing reports note rare cases of symptomatic hypotension requiring monitoring.
Why Does It Happen?
Mounjaro slows gastric emptying and causes fluid loss through GI effects, reducing blood volume and potentially dropping pressure. It doesn't directly affect blood vessels like some antihypertensives, but combining it with diuretics or other volume-depleting drugs increases risk.[1][4]
What Symptoms Should You Watch For?
Signs include dizziness, lightheadedness, fainting, blurred vision, or fatigue, especially when standing (orthostatic hypotension). Drink fluids, eat small meals, and rise slowly to manage GI side effects that contribute.[2]
Who Is at Higher Risk?
Patients with type 2 diabetes often have comorbidities like heart disease or take multiple meds, raising odds. Elderly users, those dehydrated, or on antihypertensives (e.g., ACE inhibitors) see elevated risk. Dose titration from 2.5 mg minimizes issues.[3][4]
What Do Doctors Recommend If It Happens?
Monitor blood pressure at home. Your doctor may pause dosing, hydrate via IV if severe, or adjust other meds. It's usually reversible upon discontinuation.[1][2] Report to FDA MedWatch if persistent.
How Does Mounjaro Compare to Other GLP-1 Drugs?
Similar profile to Ozempic (semaglutide) or Wegovy, where hypotension is rare (<1%) and tied to GI effects. Trulicity (dulaglutide) reports even lower rates. No head-to-head trials highlight major differences.[3]
[1]: Mounjaro Prescribing Information (FDA)
[2]: Eli Lilly Mounjaro Safety Profile
[3]: SURPASS Clinical Trial Data (NEJM)
[4]: Drugs.com Mounjaro Side Effects